Astrazeneca (AZN) Interest Coverage Ratio Growth (5y) (2014 - 2026)

Astrazeneca (AZN) Interest Coverage Ratio Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Astrazeneca 67.83 Bn 59.89 Bn 12.61 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.03%
Dec 31, 2025 -5.84%
Sep 30, 2025 -17.96%
Jun 30, 2025 -15.41%
Mar 31, 2025 -23.43%
Dec 31, 2024 -23.62%
Sep 30, 2024 -16.53%
Jun 30, 2024 -45.58%
Mar 31, 2024 -20.34%
Dec 31, 2023 11.79%
Sep 30, 2023 -16.35%
Jun 30, 2023 -36.85%
Dec 31, 2022 -6.96%
Jun 30, 2022 -23.21%
Dec 31, 2021 16.26%
Sep 30, 2021 30.09%
Mar 31, 2021 80.88%
Dec 31, 2020 -4.45%
Sep 30, 2020 5.34%
Jun 30, 2020 -7.50%